定量敏感性映射揭示了莱维体痴呆症亚型之间的差异
Rohan Bhome1,2, George E C Thomas1, Naomi Hannaway1
1Dementia Research Centre, University College London, London, WC1N 3AR, UK.
Brain : a journal of neurology
|September 4, 2025
概括
定量敏感性映射 (QSM) 显示了莱维体痴呆症 (DLB) 和帕金森病痴呆症 (PDD) 之间的铁差异. 这些发现表明DLB和PDD是不同的疾病,可能受益于向治疗和QSM作为生物标志物.
科学领域:
- 神经成像
- 神经学
- 生物标志物发现
背景情况:
- 莱维体痴呆症 (DLB) 和帕金森病痴呆症 (PDD) 是莱维体痴呆症的亚型,通常被视为一种疾病谱.
- 传统的MRI缺乏区分DLB和PDD之间潜在的神经生物学过程的灵敏度.
- 鉴定亚型特异性对于开发针对性治疗莱维体痴呆症至关重要.
研究的目的:
- 使用定量敏感性映射 (QSM) 调查DLB和PDD之间的神经生物学差异.
- 评估QSM作为莱维体痴呆症亚型和疾病严重程度的成像生物标志物的潜力.
- 探索QSM值,认知表现和整体疾病严重程度之间的关系.
主要方法:
- 对66名患有莱维体痴呆症 (45名DLB,21名PDD),86名患有帕金森病和正常认知 (PD-NC) 的患者,以及37名健康对照患者进行了定量敏感度映射 (QSM).
- 进行了素和感兴趣区域 (ROI) 分析,以比较大脑各区域的QSM值.
- 评估了QSM值与临床指标 (认知能力,运动障碍学会统一帕金森病评分表) 之间的关系.
主要成果:
- 与PD-NC相比,患有莱维体痴呆症的个体在广泛的大脑区域中表现出更高的QSM值.
- 在多个大脑区域,特别是黑色质部分,PDD的QSM值明显高于DLB.
- 在多个大脑区域中,增加的QSM值与DLB和PDD患者的整体疾病严重程度有正相关性.
结论:
- QSM检测到DLB和PDD之间明显的神经生物学差异,特别是铁沉积模式.
- DLB和PDD可能代表着不同的临床实体,这证明了亚型特定的治疗策略和临床试验设计.
- 在莱维体痴呆症临床试验中,QSM显示为一种敏感的成像生物标志物,用于评估疾病严重程度和进展.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


